Achieve Life Sciences, Inc. (ACHV)

Achieve Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	158	87	24	74	29	4
Market Cap Growth	27.68%	266.53%	-67.65%	150.99%	562.05%	-45.58%
Enterprise Value	108	88	15	46	-6	-12
PE Ratio	-	-2.92	-0.56	-2.22	-1.99	-0.27
PB Ratio	3.19	-60.22	2.87	2.62	0.79	0.25
P/FCF Ratio	-7.25	-3.56	-0.63	-2.50	-2.17	-0.29
P/OCF Ratio	-7.25	-3.56	-0.63	-2.50	-2.17	-0.29
EV/EBITDA Ratio	-4.44	-3.31	-0.38	-1.38	0.44	0.74
EV/EBIT Ratio	-4.40	-3.28	-0.38	-1.37	0.43	0.73
EV/FCF Ratio	-4.96	-3.61	-0.41	-1.55	0.47	0.78
Debt / Equity Ratio	0.35	-11.55	1.95	0.53	0.00	0.02
Debt / EBITDA Ratio	-0.72	-0.63	-0.40	-0.46	-0.01	-0.02
Debt / FCF Ratio	-0.80	-0.68	-0.43	-0.51	-0.01	-0.02
Quick Ratio	3.23	0.75	1.15	9.49	12.22	5.83
Current Ratio	3.29	0.82	1.26	9.80	12.60	6.04
Interest Coverage	-7.83	-9.45	-22.67	-	-	-
Return on Equity (ROE)	-177.00%	-936.70%	-385.50%	-99.20%	-63.70%	-137.00%
Return on Assets (ROA)	-76.60%	-127.70%	-132.00%	-80.60%	-58.30%	-106.10%
Return on Capital (ROIC)	-36.99%	-178.30%	-166.52%	-76.90%	-39.38%	-89.77%
Earnings Yield	-17.33%	-34.19%	-178.01%	-45.07%	-50.27%	-370.41%
FCF Yield	-13.62%	-28.10%	-157.91%	-40.03%	-46.04%	-344.97%
Buyback Yield / Dilution	-39.79%	-87.17%	-30.46%	-198.64%	-559.42%	-134.93%
Total Shareholder Return	-39.79%	-87.17%	-30.46%	-198.64%	-559.42%	-134.93%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).